LISI 2012
61
Thorough reorganization of the
plant at CAEN,
which specializes in
joint reconstruction (hip, knee and
shoulder). The plant has been split
into two units in order to better
meet the needs of customers:
The Forged Products UAP and the
Finished Products UAP (packaged and
sterilized). The removal of the finished
product logistics center allowed for
the freeing up of 1,000 m
2
of workshop
space to receive newmanufacturing
equipment, as well as a prototyping
unit for the manufacture of new
products within tight deadlines.
Integration of the R&D team
from Stryker Benoist Girard
into the teams of LISI MEDICAL
Orthopaedics.
This allows it to offer
customers a complete service from
support with the development of
medical equipment up to the sterile
packaged product.
Finalization of the industrial
organization of the plant at LYON,
specializing in implants for the
spinal column and for traumatology
(autonomous manufacturing units).
A dedicated unit for plastic implants
has been created. The Engineering
teamwas reinforced in order to
optimize the production of new
products.
Diversification of the customer
portfolio at the plant in Escondido
(United States)
on the spinal and
traumatology segments. Historically,
this plant was dedicated to the dental
implant sector.
KEY HIGHLIGHTS
2012
EXPERT’S
VIEW
Interview with Professor
Moussa
Hammadouche
head of the Orthopaedics department at the
Hôpital Cochin
- On what criteria do you choose implants?
With some rare exceptions, we only fit proven products which
have been the subject of published clinical evaluations, implants
with the “Gold Standard” label.
- In your opinion, what are the risks inherent in the implant itself?
Working with “Gold Standard” implants limits the risk related
to the implant to the maximum. However, risks may occur during
the evaluation of innovations. Any modification of an implant
may affect its results. The idea is to follow very strict protocols,
since the majority of modifications are for cosmetic or marketing
purposes.
-What are the principal reasons which are responsible for errors in
the selection of implants for surgery?
The first is the lack of pre-operative programming or training
and/or information available to the surgeon. Poor labeling, defi-
cient laser engraving on the ancillary or a test implant which does
not correspond to the definitive implant, can also be sources of
risk. The manufacturer must be able to guarantee that the im-
plants are compliant in all respects with the design of the original
evaluation.
-What you expect from your supplier of implants?
It must be able to guarantee irreproachable traceability of the
implants. In the event of a product recall, we must be able to
quickly inform the patients and to evaluate the associated clinical
risks. The same is also true for instruments. Many surgical centers
tend to centralize their sterilization activities, hence multiplying
the risk of mixing instruments or of incomplete ancillary boxes,
which the surgeon discovers during the operation.
